| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 378.53M | $ 335.18M | $ 319.83M | $ 278.19M | $ 298.71M |
| Gross Profit | $ 138.93M | $ 324.02M | $ 308.32M | $ 268.41M | $ 287.08M |
| Operating Income | $ 194.83M | $ 183.86M | $ 178.79M | $ 132.77M | $ 185.25M |
| EBITDA | $ 282.00M | $ 264.16M | $ 259.87M | $ 178.73M | $ 240.94M |
| Net Income | $ 142.18M | $ 137.99M | $ 135.65M | $ 66.40M | $ 111.80M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 19.62M | $ 24.29M | $ 22.35M | $ 19.29M | $ 37.41M |
| Total Assets | $ 2.80B | $ 2.61B | $ 2.49B | $ 2.51B | $ 2.84B |
| Total Debt | $ 1.16B | $ 1.15B | $ 1.14B | $ 1.15B | $ 1.25B |
| Net Debt | $ 1.14B | $ 1.12B | $ 1.11B | $ 1.13B | $ 1.21B |
| Total Liabilities | $ 1.26B | $ 1.23B | $ 1.21B | $ 1.22B | $ 1.32B |
| Stockholders' Equity | $ 1.52B | $ 1.37B | $ 1.25B | $ 1.27B | $ 1.51B |
| Cash Flow | |||||
| Free Cash Flow | $ 220.26M | $ 192.44M | $ 180.71M | $ 180.71M | $ 210.79M |
| Operating Cash Flow | $ 240.23M | $ 208.17M | $ 184.45M | $ 185.34M | $ 210.86M |
| Investing Cash Flow | $ -271.07M | $ -191.55M | $ -11.63M | $ 197.94M | $ 185.28M |
| Financing Cash Flow | $ 23.96M | $ -14.74M | $ -169.72M | $ -401.25M | $ -402.99M |
National Health Investors (CH:WX6)
:WX6
